NVIDIA
NVDA
Tesla
TSLA
Palantir
PLTR
4
Taiwan Semiconductor
TSM
5
Super Micro Computer
SMCI
US Stock MarketDetailed Quotes
BBIO BridgeBio Pharma
- 33.540
- +0.530+1.61%
Close Mar 4 16:00 ET
6.38BMarket Cap-11.65P/E (TTM)
33.920High31.690Low2.99MVolume32.720Open33.010Pre Close98.53MTurnover2.25%Turnover RatioLossP/E (Static)190.19MShares39.47052wk High-4.35P/B4.46BFloat Cap21.62052wk Low--Dividend TTM133.09MShs Float73.500Historical High--Div YieldTTM6.76%Amplitude4.980Historical Low32.965Avg Price1Lot Size
BridgeBio Pharma Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2,285.27%221.9M | 237.08%5.88M | -33.22%2.73M | 32.11%2.17M | 11,461.88%211.12M | -88.02%9.3M | -6.68%1.75M | 1,110.36%4.09M | -97.77%1.64M | 7.79%1.83M |
| Operating revenue | 2,285.27%221.9M | 237.08%5.88M | -33.22%2.73M | 32.11%2.17M | 11,461.88%211.12M | -88.02%9.3M | -6.68%1.75M | 1,110.36%4.09M | -97.77%1.64M | 7.79%1.83M |
| Cost of revenue | 58.54%3.88M | 248.49%2.08M | 0.00%598K | -0.17%598K | -8.14%598K | -28.77%2.45M | -7.57%598K | -19.08%598K | -14.43%599K | -51.71%651K |
| Gross profit | 3,079.58%218.02M | 231.12%3.8M | -38.91%2.13M | 50.67%1.57M | 17,816.77%210.52M | -90.76%6.86M | -6.21%1.15M | 971.07%3.49M | -98.57%1.04M | 239.60%1.18M |
| Operating expense | 31.19%795.39M | 26.61%225.13M | 17.62%189.26M | 21.31%174.22M | 66.80%206.78M | 11.73%606.3M | 44.84%177.81M | 30.08%160.91M | -0.84%143.61M | -18.10%123.97M |
| Selling and administrative expenses | 91.87%288.93M | 99.19%94.78M | 92.36%68.82M | 64.78%59.52M | 111.54%65.81M | 5.17%150.59M | 49.34%47.58M | 14.71%35.78M | -0.83%36.12M | -28.84%31.11M |
| Research and development costs | 11.14%506.46M | 0.10%130.35M | -3.75%120.44M | 6.70%114.7M | 51.81%140.97M | 14.08%455.71M | 43.26%130.23M | 35.27%125.14M | -0.84%107.49M | -13.74%92.86M |
| Operating profit | 3.68%-577.37M | -25.29%-221.33M | -18.87%-187.13M | -21.10%-172.65M | 103.05%3.74M | -27.97%-599.44M | -45.35%-176.66M | -26.85%-157.42M | -98.62%-142.57M | 18.69%-122.79M |
| Net non-operating interest income expense | -29.71%-82.04M | -71.12%-25.14M | -19.69%-19.77M | -10.34%-17.74M | -21.47%-19.4M | 13.23%-63.25M | 7.60%-14.69M | 5.14%-16.51M | 17.59%-16.08M | 20.47%-15.97M |
| Non-operating interest income | -4.37%17.25M | -16.05%4.68M | -13.10%3.3M | 15.09%5.2M | -1.88%4.08M | 139.17%18.04M | 36.31%5.58M | 56.93%3.79M | 489.30%4.51M | 1,455.43%4.15M |
| Non-operating interest expense | 22.14%99.29M | 47.13%29.82M | 13.57%23.06M | 11.38%22.94M | 16.65%23.47M | 1.06%81.29M | 1.39%20.27M | 2.43%20.31M | 1.55%20.59M | -1.10%20.12M |
| Other net income (expense) | 1,141.16%117.22M | -194.01%-19.76M | 867.60%42.64M | 5,688.61%114.85M | -416.55%-20.51M | -83.34%9.44M | 771.48%21.02M | -522.43%-5.56M | -102.32%-2.06M | 86.87%-3.97M |
| Gain on sale of security | -55.57%8.14M | ---- | ---- | ---- | ---- | 322.74%18.31M | ---- | ---- | 113.51%1.4M | ---- |
| Earnings from equity interest | ---31.18M | ---16.7M | ---6.56M | ---7.93M | ---- | --0 | --0 | --0 | --0 | ---- |
| Special income (charges) | 1,591.63%136.13M | -725.14%-15.34M | 985.74%49.2M | 3,563.69%122.3M | -790.18%-29.99M | 79.15%-9.13M | -43.83%2.45M | -522.43%-5.56M | 57.94%-3.53M | 88.86%-3.37M |
| -Less：Restructuring and merger&acquisition | 93.46%15.33M | 522.41%4.69M | 1,598.90%4.62M | -18.13%2.89M | -7.12%3.13M | -74.47%7.93M | -90.20%754K | -94.50%272K | -57.94%3.53M | -66.34%3.37M |
| -Less:Impairment of capital assets | --271K | --0 | --0 | --0 | --271K | --0 | --0 | --0 | --0 | --0 |
| -Less:Other special charges | --26.59M | --0 | ---- | ---- | --26.59M | ---- | ---- | ---- | ---- | ---- |
| -Gain on sale of business | 14,960.08%178.32M | --0 | --52.03M | --125.19M | ---- | ---1.2M | ---1.2M | --0 | --0 | ---- |
| -Gain on sale of property,plant,equipment | ---- | ---- | 134.01%1.8M | ---- | ---- | ---- | ---- | -183.45%-5.28M | ---- | ---- |
| Other non- operating income (expenses) | 1,515.63%4.14M | ---- | ---- | 515.79%468K | 1,677.87%9.48M | -99.76%256K | ---- | ---- | -99.93%76K | ---601K |
| Income before tax | 17.00%-542.19M | -56.31%-266.24M | 8.49%-164.25M | 52.99%-75.54M | 74.67%-36.16M | -34.79%-653.25M | -21.17%-170.33M | -28.03%-179.49M | -6,179.91%-160.7M | 29.11%-142.73M |
| Income tax | 1.15M | 0 | ||||||||
| Net income | 16.82%-543.35M | -56.98%-267.39M | 8.49%-164.25M | 52.99%-75.54M | 74.67%-36.16M | -34.79%-653.25M | -21.17%-170.33M | -28.03%-179.49M | -6,179.91%-160.7M | 29.11%-142.73M |
| Net income continuous Operations | 16.82%-543.35M | -56.98%-267.39M | 8.49%-164.25M | 52.99%-75.54M | 74.67%-36.16M | -34.79%-653.25M | -21.17%-170.33M | -28.03%-179.49M | -6,179.91%-160.7M | 29.11%-142.73M |
| Minority interest income | 24.52%-7.59M | -7.29%-2.34M | 11.05%-2.21M | 25.53%-2.09M | 63.35%-944K | -189.68%-10.05M | 26.82%-2.18M | 12.79%-2.49M | -138.43%-2.8M | 47.78%-2.58M |
| Net income attributable to the parent company | 16.70%-535.76M | -57.63%-265.05M | 8.45%-162.04M | 53.48%-73.46M | 74.87%-35.22M | -33.67%-643.2M | -22.21%-168.15M | -28.88%-177M | -1,502.06%-157.9M | 28.64%-140.16M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 16.70%-535.76M | -57.63%-265.05M | 8.45%-162.04M | 53.48%-73.46M | 74.87%-35.22M | -33.67%-643.2M | -22.21%-168.15M | -28.88%-177M | -1,502.06%-157.9M | 28.64%-140.16M |
| Basic earnings per share | 27.09%-2.88 | -45.83%-1.4 | 20.37%-0.86 | 60.20%-0.39 | 78.26%-0.2 | -21.17%-3.95 | -4.35%-0.96 | -16.13%-1.08 | -1,300.00%-0.98 | 31.85%-0.92 |
| Diluted earnings per share | 27.09%-2.88 | -45.83%-1.4 | 20.37%-0.86 | 60.20%-0.39 | 78.26%-0.2 | -21.17%-3.95 | -4.35%-0.96 | -16.13%-1.08 | -1,300.00%-0.98 | 31.85%-0.92 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |